Rocket Pharmaceuticals Inc (NASDAQ:RCKT) price on Friday, November 15, fall -5.67% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.98.
A look at the stock’s price movement, the close in the last trading session was $14.82, moving within a range at $13.8 and $14.9. The beta value (5-Year monthly) was 1.089. Turning to its 52-week performance, $32.53 and $14.65 were the 52-week high and 52-week low respectively. Overall, RCKT moved -24.15% over the past month.
Rocket Pharmaceuticals Inc’s market cap currently stands at around $1.27 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RCKT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 7 recommend RCKT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RCKT’s current price about -16.85% and -21.23% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.72, while 7-day volatility ratio is 7.62% and 5.18% in the 30-day chart. Further, Rocket Pharmaceuticals Inc (RCKT) has a beta value of 1.04, and an average true range (ATR) of 0.95. Analysts have given the company’s stock an average 52-week price target of $39, forecast between a low of $34 and high of $69. Looking at the price targets, the low is -143.2% off current price level while to achieve the yearly target high, price needs to move -393.56%. Nonetheless, investors will most likely welcome a -178.97% jump to $39 which is the analysts’ median price.
If we refocus on Rocket Pharmaceuticals Inc (NASDAQ:RCKT), historical trading data shows that trading volumes averaged 0.84 over the past 10 days and 842.75K over the past 3 months. The company’s latest data on shares outstanding shows there are 90.28 million shares.
The 7.86% of Rocket Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 98.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.9 million on 2024-10-31, giving us a short ratio of 14.81. The data shows that as of 2024-10-31 short interest in Rocket Pharmaceuticals Inc (RCKT) stood at 2767.0 of shares outstanding, with shares short rising to 11.4 million registered in 2024-09-30. Current price change has pushed the stock -53.35% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RCKT stock continues to rise going into the next quarter.
